Amgen Inc (AMGN)
314.72
-4.32
(-1.35%)
USD |
NASDAQ |
May 16, 16:00
316.10
+1.38
(+0.44%)
After-Hours: 07:14
Amgen Cash and Short Term Investments (Quarterly): 9.708B for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 9.708B |
December 31, 2023 | 10.94B |
September 30, 2023 | 34.74B |
June 30, 2023 | 34.25B |
March 31, 2023 | 31.56B |
December 31, 2022 | 9.305B |
September 30, 2022 | 11.48B |
June 30, 2022 | 7.183B |
March 31, 2022 | 6.544B |
December 31, 2021 | 8.037B |
September 30, 2021 | 12.92B |
June 30, 2021 | 8.082B |
March 31, 2021 | 10.57B |
December 31, 2020 | 10.65B |
September 30, 2020 | 12.36B |
June 30, 2020 | 11.42B |
March 31, 2020 | 8.012B |
December 31, 2019 | 8.911B |
September 30, 2019 | 20.85B |
June 30, 2019 | 21.76B |
March 31, 2019 | 26.30B |
December 31, 2018 | 29.30B |
September 30, 2018 | 29.92B |
June 30, 2018 | 29.40B |
March 31, 2018 | 32.17B |
Date | Value |
---|---|
December 31, 2017 | 41.68B |
September 30, 2017 | 41.35B |
June 30, 2017 | 39.23B |
March 31, 2017 | 38.40B |
December 31, 2016 | 38.08B |
September 30, 2016 | 37.98B |
June 30, 2016 | 35.03B |
March 31, 2016 | 34.74B |
December 31, 2015 | 31.38B |
September 30, 2015 | 31.12B |
June 30, 2015 | 29.99B |
March 31, 2015 | 27.12B |
December 31, 2014 | 27.03B |
September 30, 2014 | 28.08B |
June 30, 2014 | 26.19B |
March 31, 2014 | 19.80B |
December 31, 2013 | 19.40B |
September 30, 2013 | 22.56B |
June 30, 2013 | 22.02B |
March 31, 2013 | 21.27B |
December 31, 2012 | 24.06B |
September 30, 2012 | 25.37B |
June 30, 2012 | 22.48B |
March 31, 2012 | 19.37B |
December 31, 2011 | 20.64B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
6.544B
Minimum
Mar 2022
34.74B
Maximum
Sep 2023
14.46B
Average
10.80B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Johnson & Johnson | 26.22B |
Eli Lilly and Co | 2.586B |
Merck & Co Inc | 5.619B |
Pfizer Inc | 11.93B |
Vertex Pharmaceuticals Inc | 10.17B |